Recent evidence highlights the relationship between metabolic syndrome (MS) and
increased risk of cardiovascular (CV) diseases. Mild renal function abnormalities are …

Background Metabolic syndrome (MS) and chronic kidney disease (CKD) are well-known,
independent predictors of increased cardiovascular risk. Both conditions are fairly prevalent …

The metabolic syndrome, which is characterized by obesity, serum lipid profile alterations,
hypertension, and fasting hyperglycemia, is very common in developed countries, and its …

The metabolic syndrome (MetS) is a cluster of risk factors including insulin resistance,
dyslipidemia and hypertension which are also relevant for the development of chronic …

Metabolic syndrome (MetS) is a risk factor for the development of diabetes and
cardiovascular disease, and recently was linked to incident chronic kidney disease (CKD) …

Abstract Background and Objectives: Recently, metabolic syndrome (MS) was suggested to
be an independent risk factor for chronic kidney disease (CKD). This study explored the …

Metabolic syndrome (MetS) is a clinical syndrome that consists of visceral obesity,
dyslipidemia, hypertension, and impaired insulin sensitivity. Although individual components …

Results Eleven studies (n= 30,146) were included. MetS was significantly associated with
the development of eGFR< 60 ml/min per 1.73 m 2 (odds ratio, 1.55; 95% CI, 1.34, 1.80) …

Abstract Background/Aims: Metabolic syndrome may increase the risk for incident
cardiovascular disease (CVD) and all-cause mortality in the general population. It is unclear …

The metabolic syndrome (MS), a cluster of cardiovascular risk factors closely linked to
insulin resistance whose prevalence is high and rapidly rising in the Western population …